In vivo analysis of lung cancer metabolism: Nothing like the real thing

Christopher T. Hensley, Ralph J. De Berardinis

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

Cancer cells exhibit altered metabolism compared with that of the surrounding tissue. There is hope that these reprogrammed metabolic pathways in tumors hold the key to advances for both cancer imaging and therapy. Translation of observations in cultured cancer cells to live tumors, however, has proven to be highly complex, and robust methods to analyze metabolic activity in primary human tumors are sorely needed. In this issue of the JCI, Sellers et al. use perioperative administration of isotope-labeled glucose to lung cancer patients to differentiate metabolic pathways between tumors and benign lung. They identify pyruvate carboxylation, a reaction that enables glucose-derived carbon to replenish TCA cycle intermediates, as a key component of anabolic metabolism in tumor cells.

Original languageEnglish (US)
Pages (from-to)495-497
Number of pages3
JournalJournal of Clinical Investigation
Volume125
Issue number2
DOIs
StatePublished - Feb 2 2015

Fingerprint

Lung Neoplasms
Neoplasms
Metabolic Networks and Pathways
Glucose
Pyruvic Acid
Isotopes
Cultured Cells
Carbon
Lung

ASJC Scopus subject areas

  • Medicine(all)

Cite this

In vivo analysis of lung cancer metabolism : Nothing like the real thing. / Hensley, Christopher T.; De Berardinis, Ralph J.

In: Journal of Clinical Investigation, Vol. 125, No. 2, 02.02.2015, p. 495-497.

Research output: Contribution to journalReview article

@article{904661e0858b404bb71446d779b53d0a,
title = "In vivo analysis of lung cancer metabolism: Nothing like the real thing",
abstract = "Cancer cells exhibit altered metabolism compared with that of the surrounding tissue. There is hope that these reprogrammed metabolic pathways in tumors hold the key to advances for both cancer imaging and therapy. Translation of observations in cultured cancer cells to live tumors, however, has proven to be highly complex, and robust methods to analyze metabolic activity in primary human tumors are sorely needed. In this issue of the JCI, Sellers et al. use perioperative administration of isotope-labeled glucose to lung cancer patients to differentiate metabolic pathways between tumors and benign lung. They identify pyruvate carboxylation, a reaction that enables glucose-derived carbon to replenish TCA cycle intermediates, as a key component of anabolic metabolism in tumor cells.",
author = "Hensley, {Christopher T.} and {De Berardinis}, {Ralph J.}",
year = "2015",
month = "2",
day = "2",
doi = "10.1172/JCI79188",
language = "English (US)",
volume = "125",
pages = "495--497",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "2",

}

TY - JOUR

T1 - In vivo analysis of lung cancer metabolism

T2 - Nothing like the real thing

AU - Hensley, Christopher T.

AU - De Berardinis, Ralph J.

PY - 2015/2/2

Y1 - 2015/2/2

N2 - Cancer cells exhibit altered metabolism compared with that of the surrounding tissue. There is hope that these reprogrammed metabolic pathways in tumors hold the key to advances for both cancer imaging and therapy. Translation of observations in cultured cancer cells to live tumors, however, has proven to be highly complex, and robust methods to analyze metabolic activity in primary human tumors are sorely needed. In this issue of the JCI, Sellers et al. use perioperative administration of isotope-labeled glucose to lung cancer patients to differentiate metabolic pathways between tumors and benign lung. They identify pyruvate carboxylation, a reaction that enables glucose-derived carbon to replenish TCA cycle intermediates, as a key component of anabolic metabolism in tumor cells.

AB - Cancer cells exhibit altered metabolism compared with that of the surrounding tissue. There is hope that these reprogrammed metabolic pathways in tumors hold the key to advances for both cancer imaging and therapy. Translation of observations in cultured cancer cells to live tumors, however, has proven to be highly complex, and robust methods to analyze metabolic activity in primary human tumors are sorely needed. In this issue of the JCI, Sellers et al. use perioperative administration of isotope-labeled glucose to lung cancer patients to differentiate metabolic pathways between tumors and benign lung. They identify pyruvate carboxylation, a reaction that enables glucose-derived carbon to replenish TCA cycle intermediates, as a key component of anabolic metabolism in tumor cells.

UR - http://www.scopus.com/inward/record.url?scp=84922130204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922130204&partnerID=8YFLogxK

U2 - 10.1172/JCI79188

DO - 10.1172/JCI79188

M3 - Review article

C2 - 25607834

AN - SCOPUS:84922130204

VL - 125

SP - 495

EP - 497

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 2

ER -